Pain Clinical Trial
— LMA vs SpinalOfficial title:
Spinal Versus General Anesthesia With Popliteal and Adductor Canal Blocks for Ambulatory Foot and Ankle Surgery: A Double-Blinded Randomized Controlled Trial.
NCT number | NCT02996591 |
Other study ID # | 2016-0499 |
Secondary ID | |
Status | Completed |
Phase | Phase 4 |
First received | |
Last updated | |
Start date | January 2017 |
Est. completion date | May 2017 |
Verified date | November 2019 |
Source | Hospital for Special Surgery, New York |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to determine if there is a difference in patient outcomes with
general anesthesia versus spinal anesthesia when given in addition to popliteal and adductor
canal nerve blocks for foot and ankle surgery. Popliteal and adductor canal nerve blocks are
injections of local anesthetic agents near nerves in the back and front of the knee going to
the foot and ankle that provide numbness during and after surgery. These peripheral nerve
blocks offer good pain control and reduce the need for opioids (opioids are pain medications
such as morphine, Dilaudid, and oxycodone). General anesthesia involves the flow of oxygen
and anesthesia gas through a tube which, along with additional intravenous medications,
causes unconsciousness and unawareness of sensations during surgery. Spinal anesthesia
involves an injection of local anesthetic in the lower back, which causes numbness below the
waist. In addition to spinal anesthesia, a sedative is typically given intravenously to cause
relaxation and sleepiness throughout surgery.
General, spinal, and nerve block anesthesia are all routinely used for surgery at the
Hospital for Special Surgery. General or spinal anesthesia is typically used in addition to
peripheral nerve blocks during foot and ankle surgery to 1) allow the surgeons to use a thigh
tourniquet to reduce bleeding, 2) provide anesthesia earlier, and 3) prevent unwanted
movement. However, it is unclear whether general or spinal anesthesia provides better patient
outcomes when given with peripheral nerve blocks. Some reports show that on its own, spinal
anesthesia has advantages over general anesthesia in terms of side effects such as nausea and
pain. However, these advantages may also be gained from combining peripheral nerve blocks
with general anesthesia. Spinal anesthesia can be associated with headache and backache,
although headache and backache can also happen after operations performed with general
anesthesia. A previous study at the Hospital for Special Surgery showed low rates of nausea
among patients who received nerve blocks with spinal anesthesia, and no nausea among patients
who received a nerve block with general anesthesia. Therefore, the primary aim of this study
is to determine if, as a treatment, either general or spinal anesthesia has advantages over
the other treatment in terms of readiness for discharge, side effects, pain and patient
satisfaction in an ambulatory foot and ankle population.
Status | Completed |
Enrollment | 36 |
Est. completion date | May 2017 |
Est. primary completion date | May 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - 18-75 aged patients - American Society of Anesthesiologists (ASA) Physical Status classification 1-3 - Elective foot and ankle day surgery procedures, lasting between 1 and 3 hours as per surgeon, performed by 3 co-investigator surgeons. - Planned for combined popliteal and adductor canal block - No contraindications for spinal or LMA general anesthesia Exclusion Criteria: - Incapable of providing informed consent - Contraindications for regional or LMA anesthesia (anticoagulation, infection at injection site) - Anticipated difficult airway - BMI>40 - Anticipated surgical procedure time less than 1 hour or more than 3 hours - Hx of severe postoperative nausea and vomiting - ASA >3 - Peripheral neuropathy affecting the operative extremity - Pregnant or nursing women - Chronic opioid use (daily use of opioids one month prior to surgery/ patients requiring chronic pain interventions) - Prone position - Obstructive sleep apnea with planned admission overnight to the hospital - Known allergy/sensitivity to any study medications - Planned admission after surgery - Non-English speaking |
Country | Name | City | State |
---|---|---|---|
United States | Hospital for Special Surgery, New York | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Hospital for Special Surgery, New York |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time Until Patient is Ready for Discharge From Post-Anesthesia Care Unit (PACU) to Home. | Modified Aldrete Scoring System and Marshall and Chung Postanesthesia Discharge Scoring System, measured in time until discharge criteria is met (in minutes) | Duration of stay in recovery room after surgery | |
Secondary | Numerical Rating Scale (NRS) Pain Scores at 1 Hour Postop | NRS Pain scores at 1 hour after surgery. Rated on a scale of 0 (no pain) to 10 (worst pain imaginable). | 1 hour after PACU admission | |
Secondary | Numerical Rating Scale Pain Scores at 2 Hours Postop | Numerical rating scale pain score as reported by the patient at 2 hours post-operatively. Rated on a scale of 0 (no pain) to 10 (worst pain imaginable). | 2 hours after PACU admission | |
Secondary | Numerical Rating Scale Pain Scores on Postoperative Day (POD) 1 | Numerical Rating Scale Pain from 0-10. 0 being no pain at all. 10 being the worst pain imaginable. | 24 hours after surgery | |
Secondary | Postoperative Discomfort and Needs (Post-op Pain, Sore Throat, Back Pain, Nausea, Cold, Hunger, Thirst) | Leiden Perioperative Care Patient Satisfaction questionnaire (LPPSq) score. Performed at 1 hour postoperatively. To what degree did patients have the following symptoms. Rated 1-5, 1 being not at all. 5 being extremely. | 1 hour after surgery | |
Secondary | Postoperative Discomfort and Needs (Post-op Pain, Sore Throat, Back Pain, Nausea, Cold, Hunger, Thirst) | Rating the Nausea/Vomiting of patients post-operatively. | 2 hours after surgery | |
Secondary | Postoperative Discomfort and Needs (Post-op Pain, Sore Throat, Back Pain, Nausea, Cold, Hunger, Thirst) | Leiden Perioperative Care Patient Satisfaction questionnaire (LPPSq). From 1-5. 1 being not at all. 5 being extremely. | Postoperative day 1 | |
Secondary | Incidence of Post-dural Puncture Headache | Postoperative day 1 and if present, monitored until resolution | ||
Secondary | Incidence of Transient Neurologic Symptoms | Postoperative day 1 and if present, monitored until resolution | ||
Secondary | Opioid Consumption | Opioid consumption (mg OME) during inpatient stay | Duration of stay in recovery room after surgery (average 2 hours) | |
Secondary | Opioid Consumption Through First Postoperative Day. Measured in mg OME | Postoperative day 1 | ||
Secondary | Non-opioid Analgesic Consumption | The number of patients who took non-opioid analgesic medication for post-operative pain between hospital discharge and postoperative day 1. | Hospital discharge to postoperative day 1 | |
Secondary | Opioid-Related Symptom Distress Scale (ORSDS) Score | Opioid-related symptom distress scale. The ORSDS measures patient opioid-related symptoms on a 4-point scale that evaluates 3 symptom distress dimension (severity, frequency, and bothersomeness) for 12 opioid-related symptoms. Scores range from 0-4, and the mean of the 12 answers is the ORSDS score. Higher values indicate worse opioid-related symptoms. | 2 hours after surgery | |
Secondary | Cognitive Recovery | Postoperative Quality Recovery Scale Cognitive Domain questionnaire. Asked at 1 hour post-operatively. Either yes (return to pre-operative cognitive function levels) or no (not yet returned to pre-operative function levels) | 1 hour after surgery | |
Secondary | Incidence of Urinary Catheterization | Duration of stay in recovery room after surgery (average 2 hours) | ||
Secondary | Anesthesia-related Postoperative Complications | Measuring any anesthesia-related post-op complications that occured (yes or no) | Surgery start to postoperative day 1 | |
Secondary | Assessment of Patient Blinding to Group Assignment | Patients will be asked whether they believe they were in the general anesthesia or spinal anesthesia group. These responses are then validated using the Bang Blinding Index, which either confirms or refutes the validity of the blinding. The scale runs from -1 to 1, with a score of 0 indicating complete blinding, -1 indicating opposite guessing of groups, and 1 indicating a complete lack of blinding. | Postoperative day 1 | |
Secondary | Patient Satisfaction | Yes/no if patients would request the same anesthetic that they received | POD1 | |
Secondary | Cognitive Recovery at 2 Hours Post-operative | Postoperative Quality Recovery Scale Cognitive Domain questionnaire. Asked at 2 hour post-operatively. Either yes (return to pre-operative cognitive function levels) or no (not yet returned to pre-operative function levels) | 2 hours after PACU admission | |
Secondary | Cognitive Recovery on POD1 | Postoperative Quality Recovery Scale Cognitive Domain questionnaire. Asked on postoperative day 1. Either yes (return to pre-operative cognitive function levels) or no (not yet returned to pre-operative function levels) | Postoperative day 1 | |
Secondary | Nausea Intensity | Nausea intensity ranked on NRS score following PACU admission to 2 hours after discharge. Scored from 0-10. 0 Being no nausea, 10 being worst nausea imaginable. | 2 hours after PACU admission | |
Secondary | Back Pain on POD1 | Back pain (yes/no) on POD1 | Postoperative day 1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05559255 -
Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI
|
N/A | |
Completed |
NCT04748367 -
Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care
|
N/A | |
Terminated |
NCT04356352 -
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
|
Phase 2/Phase 3 | |
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04466111 -
Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
|
||
Recruiting |
NCT05868122 -
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
|
Phase 3 | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Enrolling by invitation |
NCT06087432 -
Is PNF Application Effective on Temporomandibular Dysfunction
|
N/A | |
Completed |
NCT05508594 -
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
|
Phase 2/Phase 3 | |
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Completed |
NCT03678168 -
A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries
|
N/A | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT03286543 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
|
N/A | |
Completed |
NCT02913027 -
Can We Improve the Comfort of Pelvic Exams?
|
N/A | |
Terminated |
NCT02181387 -
Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?
|
Phase 4 | |
Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
Active, not recruiting |
NCT03613155 -
Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care
|